Delivery Order SPE2DB22D2206-SPE2DB24FJA06

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Mounjaro 15 mg/0.5 ml pens. The delivery order contract, valued at $2,659.20, is a firm fixed-price agreement with a completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $3,156.00 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,052.00 to the Corporate Office Division of Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This contract is for the supply of the pharmaceutical product "MOUNJARO 15 MG/0.5 ML PEN 0.5ML" with a completion date of April 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price Delivery Order contract valued at $5,590.62 for the supply of Mounjaro 5 mg/0.5 ml pens. The contract has a performance period through March 12, 2024. This Delivery Order was issued under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. This IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a $29,820.51 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Amerisourcebergen's single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a $3,623.82 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of Mounjaro 5 mg/0.5 ml pens, with a completion date of July 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a wide range of...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Mounjaro 7.5 mg/0.5 ml pens to the U.S. government. The contract, valued at $30,363.92, was awarded by the Defense Logistics Agency (DLA) and has a completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to...
The Defense Logistics Agency (DLA) awarded a $3,208.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This contract has a completion date of May 14, 2024 and was awarded on May 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a $16,107.36 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp (Corporate Office Division) for the supply of 4565735719 Mounjaro 7.5 mg/0.5 ml pens. The contract has a completion date of September 10, 2024 and is not designated as a set-aside. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, including a...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,156.00 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. This contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period through May 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJA06
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $3,156.00, for the supply of Mounjaro 10 mg/0.5 ml pens. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This federal contract award was not set aside for any specific business type.

Generated 10/1/24, 12:32 PM